✦ LIBER ✦

TH1/TH2 Cytokine profile in relapsing-remitting multiple sclerosis patients treated with Glatiramer acetate or Natalizumab

✍ Scribed by Celia Oreja-Guevara, Jaime Ramos-Cejudo, Luiz Stark Aroeira, Beatriz Chamorro, Exuperio Diez-Tejedor

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A longitudinal observational study of a

✍ M. Debouverie; T. Moreau; C. Lebrun; O. Heinzlef; F. Brudon; J. Msihid 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 188 KB

Cost-Effectiveness Analyses of Natalizum

✍ Nishikawa, A.M.; Paladini, L.; Liamas, A.L.; Bueno, C.C.; Clark, O.A.C. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

Glatiramer Acetate-Specific Antibody Tit

✍ R. Bomprezzi; R. Schafer; V. Reese; A. Misra; T. L. Vollmer; M. Kala 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 285 KB

Elevated melatonin levels in natalizumab

✍ Bahamonde, Carmen; Conde, Cristina; Agüera, Eduardo; Lillo, Rafael; Luque, Eveli 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 914 KB

Spasticity improvement in patients with

✍ J.E. Meca-Lallana; J.J. Balseiro; F. Lacruz; C. Guijarro; O. Sanchez; A. Cano; L 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 416 KB

Cost analysis of glatiramer acetate vs.

✍ Rainel Sanchez-de la Rosa, Eliazar Sabater, Miguel A Casado 📂 Article 📅 2013 🏛 Springer-Verlag 🌐 English ⚖ 206 KB